These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25940785)

  • 1. Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection.
    Thouennon E; Cheng Y; Falahatian V; Cawley NX; Loh YP
    J Neurochem; 2015 Aug; 134(3):463-70. PubMed ID: 25940785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.
    Fuenzalida K; Quintanilla R; Ramos P; Piderit D; Fuentealba RA; Martinez G; Inestrosa NC; Bronfman M
    J Biol Chem; 2007 Dec; 282(51):37006-15. PubMed ID: 17965419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent.
    Chiang MC; Cheng YC; Nicol CJ; Lin CH
    Int J Biochem Cell Biol; 2017 Nov; 92():121-133. PubMed ID: 28964868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone.
    Cheng Y; Rodriguiz RM; Murthy SR; Senatorov V; Thouennon E; Cawley NX; Aryal DK; Ahn S; Lecka-Czernik B; Wetsel WC; Loh YP
    Mol Psychiatry; 2015 Jun; 20(6):744-54. PubMed ID: 25330741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E, protects human neurons against oxidative/neuroexcitotoxic stress via β-arrestin/ERK signaling.
    Sharma VK; Yang X; Kim SK; Mafi A; Saiz-Sanchez D; Villanueva-Anguita P; Xiao L; Inoue A; Goddard WA; Loh YP
    Cell Mol Life Sci; 2021 Dec; 79(1):24. PubMed ID: 34966948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner.
    Wei JY; Hu MY; Chen XQ; Lei FY; Wei JS; Chen J; Qin XK; Qin YH
    Ren Fail; 2022 Dec; 44(1):2056-2065. PubMed ID: 36420656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells.
    Chiang MC; Cheng YC; Nicol CJ; Lin KH; Yen CH; Chen SJ; Huang RN
    Exp Cell Res; 2015 Nov; 338(2):183-93. PubMed ID: 26362846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor Yellow A Shows Protection against PPAR
    Sun L; Xu YW; Han J; Xiao C; Cao SS; Liang H; Cheng Y
    Oxid Med Cell Longev; 2018; 2018():9101740. PubMed ID: 30410641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function.
    Liu ZJ; Liu HQ; Xiao C; Fan HZ; Huang Q; Liu YH; Wang Y
    J Neurosci Res; 2014 Nov; 92(11):1549-59. PubMed ID: 24975470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase.
    Okami N; Narasimhan P; Yoshioka H; Sakata H; Kim GS; Jung JE; Maier CM; Chan PH
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):106-14. PubMed ID: 23032483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone activation of PPARγ-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress.
    Chiang MC; Nicol CJ; Cheng YC; Lin KH; Yen CH; Lin CH
    Neurobiol Aging; 2016 Apr; 40():181-190. PubMed ID: 26973118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
    Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
    Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
    Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy.
    Wong SB; Cheng SJ; Hung WC; Lee WT; Min MY
    PLoS One; 2015; 10(12):e0144806. PubMed ID: 26659605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.
    Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E
    Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.